Washington Trust Bank’s Immunogen Inc IMGN Stock Holding History

Washington Trust Bank’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-158	Closed	–	–	1199
2016 Q2	$0	Hold	158	–	–	﹤0.01%	873
2016 Q1	$1K	Buy	+158	New	+$1.34K	﹤0.01%	751

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Washington Trust Bank's IMGN Position: Q3 2016 in Review

Washington Trust Bank sold out of Immunogen Inc (IMGN) in Q3 2016, closing a stake of 158 shares.

Washington Trust Bank first reported a position in IMGN in Q1 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2016. 155 funds tracked by Wall St. Rank hold IMGN as of Q3 2016.

Washington Trust Bank reported no remaining Immunogen Inc position as of Q3 2016 after selling out during the quarter.
Washington Trust Bank sold 158 Immunogen Inc shares in Q3 2016.
Washington Trust Bank first reported a position in Immunogen Inc in Q1 2016 and held it in 2 quarters.
Washington Trust Bank's Immunogen Inc position peaked at $1K in Q1 2016.
155 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2016.

Based on Washington Trust Bank's 13F filing for Q3 2016, filed 4 Oct 2016.